Extendicare Inc. (OTCMKTS:EXETF – Get Free Report)’s stock price dropped 0.9% during trading on Tuesday. The company traded as low as $18.87 and last traded at $18.89. 331,330 shares were traded during trading, an increase of 462% from the average daily volume of 58,940 shares. The stock had previously closed at $19.07.
Analyst Upgrades and Downgrades
Several research firms have issued reports on EXETF. Royal Bank Of Canada reaffirmed an “outperform” rating on shares of Extendicare in a report on Friday, August 14th. Canadian Imperial Bank of Commerce reissued an “outperform” rating on shares of Extendicare in a research report on Monday, August 10th. Five equities research analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company has an average rating of “Buy”.
Get Our Latest Stock Report on EXETF
Extendicare Stock Up 0.2%
About Extendicare
Extendicare Inc is a Canadian provider of continuing health-care and senior-living services. The company operates long-term care homes that provide accommodation, nursing care, rehabilitation and other support services for older adults with complex or ongoing care needs.
Through its retirement-living operations, Extendicare also provides independent and assisted-living accommodations, along with dining, wellness and personal-support services. Its ParaMed business delivers home health-care services, including nursing, personal support, therapy and rehabilitation, helping clients remain in their homes and communities.
Extendicare traces its history to 1968 and serves communities across several Canadian provinces, with a significant presence in Ontario.
Featured Stories
- Five stocks we like better than Extendicare
- Want Private-Market Access to Kalshi and Polymarket? Try This ETF
- Levi’s Stock Dip Reveals Value Opportunity Despite Q3 Headwinds
- PepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value
- Alphabet’s $1.8 Billion Black Hills Deal Powers AI Data Center Push
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
